Lundbeckfonden Emerge, based in Copenhagen, Denmark, was founded in 2012 as a corporate investor. The fund focuses on investing in life science startups, particularly in the pharmaceutical and medical sectors. It typically invests in rounds with three participants and seeks out startups that are 2-3 years old. Lundbeckfonden Emerge has a track record of investing in successful companies such as NMD Pharma and AFYX Therapeutics. In addition to providing financing, the fund also offers advice and active project management to optimize the outcome of the ventures.